Press Releases April 22, 2026 05:24 PM

Oxford Square Capital Corp. Schedules First Quarter 2026 Earnings Release and Conference Call for April 29, 2026

Oxford Square Capital Corp. announces Q1 2026 earnings release and conference call scheduled for April 29, 2026.

By Marcus Reed
Share
Twitter Reddit Facebook LinkedIn
OXSQ

Oxford Square Capital Corp., a publicly-traded business development company specializing in syndicated bank loans and collateralized loan obligation investments, will release its first quarter 2026 earnings on April 29, 2026, followed by a conference call to discuss the results.

Oxford Square Capital Corp. Schedules First Quarter 2026 Earnings Release and Conference Call for April 29, 2026
OXSQ
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Earnings release for Q1 2026 scheduled for April 29, 2026, at 9:00 AM Eastern time.
  • Conference call to review earnings will follow the release, accessible via toll-free dial-in and replay options.
  • Company primarily invests in syndicated bank loans and debt/equity tranches of CLO vehicles.
  • Sectors impacted include financial services, specifically loan and credit markets.

GREENWICH, Conn, April 22, 2026 (GLOBE NEWSWIRE) -- Oxford Square Capital Corp. (NasdaqGS: OXSQ) (NasdaqGS: OXSQG) (NasdaqGS: OXSQH) announced today that it will hold a conference call to discuss first quarter 2026 earnings on Wednesday, April 29, 2026 at 9:00 AM Eastern time. The toll free dial-in number is 1-800-715-9871, access code number 2511724. There will be a recorded replay of the call available for 30 days after the call. If you are interested in hearing the recording, please dial 1-800-770-2030. The replay pass-code is 2511724#.

About Oxford Square Capital Corp.
Oxford Square Capital Corp. is a publicly-traded business development company principally investing in syndicated bank loans and, to a lesser extent, debt and equity tranches of collateralized loan obligation (“CLO”) vehicles. CLO investments may also include warehouse facilities, which are financing structures intended to aggregate loans that may be used to form the basis of a CLO vehicle.

Contact:
Bruce Rubin
203-983-5280


Risks

  • Market fluctuations could impact the valuation of syndicated loans and CLO investments held by the company.
  • Regulatory changes affecting business development companies or CLO structures may affect operations.
  • Credit risk inherent in bank loans and CLO tranches could influence earnings results.

More from Press Releases

Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026 ROMA Green Finance Establishes Dedicated Artificial Intelligence and High-Performance Computing Infrastructure Investment Vertical Jun 12, 2026 Traws Pharma Provides Regulatory Update on Influenza Program Jun 12, 2026 Heartland Express, Inc. Declares Regular Quarterly Dividend Jun 12, 2026